The antiphospholipid syndrome is a bioclinical entity defined by thrombosis and/or
obstetrical complications in the presence, at least 12 weeks apart, of antiphospholipid …

Antiphospholipid antibodies are a wide and heterogeneous group of immunoglobulins,
whose presence in patients with arterial and venous thrombosis, and obstetrical …

See also Galli M. The antiphospholipid triangle. This issue, pp 234–6. Summary
Background: The characteristics and the clinical course of antiphospholipid syndrome (APS) …

Introduction: As soon as the association of lupus anticoagulant (LAC) and anticardiolipin
antibodies (aCL) with thrombosis and miscarriages was described in the 1980s, the …

Background Antiphospholipid syndrome (APS) is an autoimmune condition that is
diagnosed by the presence of at least one of the clinical manifestations (thrombosis and/or …

The antiphospholipid antibody syndrome (APS) is defined by two major elements: the
presence in plasma of auto‐antibodies, ie antiphospholipid antibodies and the occurrence …

The antiphospholipid syndrome is characterized by the presence of arterial or venous
thrombosis or recurrent miscarriages in a patient with positive laboratory tests for …

The antiphospholipid syndrome (APS) is defined by thrombotic and/or obstetric events
together with the presence of antiphospholipid antibodies in plasma of patients. The original …

Antiphospholipid syndrome (APS) is an autoimmune condition characterized by the
presence of antiphospholipid antibodies (aPL) in subjects presenting with thrombosis and/or …

Antiphospholipid syndrome is a multisystem autoimmune disease, characterized by
recurrent vascular thrombosis and/or pregnancy losses in the presence of persistently …